Product > Plant Extracts > 

Coriolus versicolor Extract,China WUYANGTANG price supplier

Coriolus versicolor Extract
min.order / fob price
≥1 piece
OriginZHEJIANG
Production Capacity10 Metric Ton per Quarter
CategoryPlant Extracts
Update Time2023-02-16
company profile
Zhejiang Wuyangtang Pharmaceutical Co., Ltd.
China
Contact: Ms.Vivi Pan
Tel: 0086-0000-00000
Number of Employees: 50 ~ 100
Business Type: Manufacture
product details
Standard:Not less than 30%
Origin:ZHEJIANG
Brand:WUYANGTANG
Product Name
Coriolus versicolor Extract
Coriolus versicolor extract is a product of active ingredients isolated and purified from coriolus versicolor, also called Trametes versicolor in English. It is an extremely common polypore mushroom which can be found throughout the world. T. versicolor is recognized as a medicinal mushroom in Chinese medicine under the name yun zhi. In China and Japan T. versicolor is used as in immunoadjuvant therapy for cancer
 
 Enlarge
Nutrients
Coriolus versiclor is rich in protein, fat, polysaccharides, peptidoglycan and all glucosan, triterpenes, lignin, multi-amino acid and microelement. The water-extracted protein-bound polysaccharide krestin (PSK) and polysaccharide peptide (PSP) polysaccharides of C. versicolor have immunomodulating and antitumor activity. They are chemically similar but distinguished by fucose in PSK and rhamnose and arabinose in PSP. The polypeptide component contains mostly glutamic and aspartic acids and the polysaccharides contain primarily alpha-1,4 and beta-1,3 glucosidic linkages.
Medicinal use and research
Polysaccharide-K (KrestinPSK), is a protein-bound polysaccharide isolated from Trametes versicolor, which is used as an immune system boosting agent in the treatment of cancer in some European countries as well as China and Japan. In Japan, PSK is approved as an adjuvant for cancer therapy and is covered by government health insurance.
PSK has documented anticancer activity in vitro, in vivo and in human clinical trials. Research has also demonstrated that the PSK can reduce mutagen-induced, radiation-induced, and spontaneously-induced cancer development. PSK has shown to be beneficial as an adjuvant in the treatment of gastric, esophageal, colorectal, breast and lung cancers. Human clinical trials suggest PSK can reduce cancer recurrence when used as an adjuvant Further in vitro studies have shown that a nutraceutical blend (MC-S) of PSK, lentinan and other fungal extracts can also inhibit cancer cell proliferation.
An in vitro study with PSP demonstrated antiviral activity against human immunodeficiency virus type 1 infection (HIV-1).
 
You Might Also Like
 
Post Sourcing RequestContact Supplier